Search research articles
Contact Us
Filters
Showing results (91-100 of 136) with videos related to
Page
of 14
Sort By:
The Journal of Hand Surgery, European Volume
|
November 9, 2012
Biomechanical assessment of a novel tendon junction
T Crook, J Tawfik, N Bertollo, et al.
Psychopharmacology Bulletin
|
January 1, 1989
Differential effects of antihypertensive medications on cognitive functioning
A Sudilovsky, S Croog, T Crook, et al.
Lancet (London, England)
|
May 2, 1992
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours
T Crook, D Wrede, J A Tidy, et al.
Clinical and Experimental Dermatology
|
November 28, 2001
Sézary syndrome with a complex, frameshift p53 gene mutation in a Chernobyl survivor
E A Fraser-Andrews, J M McGregor, T Crook, et al.
The EMBO Journal
|
February 15, 1994
HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes
E W Lam, J D Morris, R Davies, et al.
Oncogene
|
December 19, 1996
Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7
G A Parker, T Crook, M Bain, et al.
Oncogene
|
April 1, 1993
Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling
J D Morris, T Crook, L R Bandara, et al.
British Journal of Cancer
|
January 1, 1997
Analysis of somatostatin receptor subtype mRNA expression in human breast cancer
A A Evans, T Crook, S A Laws, et al.
The EMBO Journal
|
August 1, 1992
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription
M S Lechner, D H Mack, A B Finicle, et al.
British Journal of Cancer
|
May 14, 2009
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer
R Shah, P Smith, C Purdie, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 136) with videos related to
Sort By:
Page
of 14
The Journal of Hand Surgery, European Volume
|
November 9, 2012
Biomechanical assessment of a novel tendon junction
T Crook, J Tawfik, N Bertollo, et al.
Psychopharmacology Bulletin
|
January 1, 1989
Differential effects of antihypertensive medications on cognitive functioning
A Sudilovsky, S Croog, T Crook, et al.
Lancet (London, England)
|
May 2, 1992
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours
T Crook, D Wrede, J A Tidy, et al.
Clinical and Experimental Dermatology
|
November 28, 2001
Sézary syndrome with a complex, frameshift p53 gene mutation in a Chernobyl survivor
E A Fraser-Andrews, J M McGregor, T Crook, et al.
The EMBO Journal
|
February 15, 1994
HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes
E W Lam, J D Morris, R Davies, et al.
Oncogene
|
December 19, 1996
Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7
G A Parker, T Crook, M Bain, et al.
Oncogene
|
April 1, 1993
Human papillomavirus type 16 E7 regulates E2F and contributes to mitogenic signalling
J D Morris, T Crook, L R Bandara, et al.
British Journal of Cancer
|
January 1, 1997
Analysis of somatostatin receptor subtype mRNA expression in human breast cancer
A A Evans, T Crook, S A Laws, et al.
The EMBO Journal
|
August 1, 1992
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription
M S Lechner, D H Mack, A B Finicle, et al.
British Journal of Cancer
|
May 14, 2009
The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer
R Shah, P Smith, C Purdie, et al.
Page
of 14